- $392.73m
- $910.13m
- $1.03bn
- 57
- 83
- 78
- 86
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19.25 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.75 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 8.29 | ||
| Price to Sales | 0.38 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -10.47% | ||
| Return on Equity | -26.18% | ||
| Operating Margin | -11.12% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1,078.2 | 1,106.6 | 1,071.1 | 1,046.3 | 1,034.8 | 1,069.11 | 1,120.48 | -1.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +214.8 | +40.21 | -77.12 | n/a | n/a | n/a | +18.32 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Enhabit, Inc. is a provider of home health and hospice services in the United States. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. It works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. It operates about 115 hospice agencies and 255 home health agencies.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 20th, 2014
- Public Since
- June 23rd, 2022
- No. of Shareholders
- 5,500
- No. of Employees
- 10,700
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 50,479,951
- Address
- 6688 N. Central Expressway, Suite 1300, DALLAS, 75206
- Web
- https://www.ehab.com/
- Phone
- +1 4696216419
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for EHAB
Q1 2025 Enhabit Inc Earnings Call
Enhabit Inc Annual Shareholders Meeting
Q2 2025 Enhabit Inc Earnings Release
Similar to EHAB
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners
New York Stock Exchange
Auna SA
New York Stock Exchange
FAQ
What is the Enhabit share price?
As of Today at 20:28 UTC, shares in Enhabit are trading at $7.78. This share price information is delayed by 15 minutes.
How has the Enhabit share price performed this year?
Shares in Enhabit last closed at $7.78 and the price had moved by -21.18% over the past 365 days. In terms of relative price strength the Enhabit share price has underperformed the S&P500 Index by -27.24% over the past year.
What are the analyst and broker recommendations for Enhabit?
The overall consensus recommendation for Enhabit is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Enhabit dividend yield?
Enhabit does not currently pay a dividend.
Does Enhabit pay a dividend?
Enhabit does not currently pay a dividend.
When does Enhabit next pay dividends?
Enhabit does not currently pay a dividend.
How do I buy Enhabit shares?
To buy shares in Enhabit you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Enhabit?
As of the previous close price of $7.78, shares in Enhabit had a market capitalisation of $392.73m.
Where are Enhabit shares listed?
Here are the trading details for Enhabit:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: EHAB
What kind of share is Enhabit?
Based on an overall assessment of its quality, value and momentum Enhabit is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Enhabit share price forecast for 2025?
The analyst consensus target price for shares in Enhabit is $9.00. That is 15.68% above the last closing price of $7.78.
Analysts covering Enhabit currently have a consensus Earnings Per Share (EPS) forecast of $0.38 for the next financial year.
Find out moreWhat is the trend in the Enhabit share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Enhabit. Over the past six months, its share price has outperformed the S&P500 Index by +16.48%.
As of the last closing price of $7.78, shares in Enhabit were trading -4.91% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Enhabit PE Ratio?
The Enhabit PE ratio based on its reported earnings over the past 12 months is 19.25. The shares last closed at $7.78.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Enhabit?
We do not have data on Enhabit's directors